NRBO - NeuroBo Bozor kapitallashuvining daromadga nisbati
NeuroBo Pharmaceuticals (NRBO) uchun xavflar biomateriallarning qimmat termal logistikasi bilan bog'liq bo'lib, bu ta'minot zanjirlarini murakkablashtiradi. Sotuvlarga nisbatan narx koeffitsiyenti barqarorlik ko'rsatkichi vazifasini o'taydi, bunda darajasi joriy qiymatdir. Ijobiy kayfiyatni semizlik va MASH davolash vositalarining tijorchashtirilishiga tikilgan garovlar, shuningdek, sog'liqni saqlash gigantlari tomonidan qo'llab-quvvatlanadigan klinik sinovlarning o'rta bosqich natijalari kutilayotgani harakatga keltirmoqda.
NeuroBo Pharmaceuticals (NRBO) kompaniyasi koʻrsatkichlari kesimi va tahlili
- joriy kotirovkalar va o'rtacha qiymat prognozi:
- bozor kapitallashuvi statistikasi:
- balans kapitallashuvi ko'rsatkichlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Umumiy qarzning kapitalga nisbati NeuroBo Pharmaceuticals|NRBO - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati neurobopharma.com|NRBO - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati NeuroBo Pharma|NRBO - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli qarzlari NeuroBo Pharmaceuticals|Tezkor likvidlik ko‘rsatkichi neurobopharma.com
- foyda va baholash multiplikatorlari ko'rsatkichlari:
NRBO - Sof foyda|Kutilayotgan sof foyda NeuroBo Pharmaceuticals|NRBO - Narx-foyda koeffitsiyenti|Forvard P/E multiplikatori NeuroBo Pharmaceuticals|NRBO - Narx-foyda va o‘sish multiplikatori|Korxona qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati koeffitsiyenti NeuroBo Pharma|NRBO - EBITDA operatsion foydasi|So'nggi to'rtta chorak uchun bir aksiya uchun sof foyda NeuroBo Pharmaceuticals|NRBO - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi 12 oy davomida bir aksiya uchun sof foydaning yillik o'sishi neurobopharma.com|NRBO - Joriy yilda foyda o'sishi|Keyingi yil uchun foyda o'sishi prognozi NeuroBo Pharmaceuticals
- emitentning tushumi va sotuvlari tafsilotlari:
Kompaniyaning fundamental tahlili:NRBO (NeuroBo Pharmaceuticals, Inc.)
Semizlikka qarshi dori vositalarini ishlab chiquvchi NeuroBo Pharmaceuticals (NRBO) uchun ushbu koeffitsient kompaniyaning bozor qiymatini uning joriy savdo ko'rsatkichlariga nisbatan belgilaydi. Biznesning bahosini P/S orqali tahlil qilish orqali investor bozor kapitalizatsiyasini daromadlar hajmi bilan solishtiradi, bu esa yangi dori vositalari uchun ommaviy sug'urta to'lovlari kutilayotgan bir paytda aksiya narxining asoslanganligini baholash imkonini beradi hamda potensial chegirmani yoki aktivlarning yetarlicha baholanmaganligi xatarlarini aniqlashga yordam beradi.
Raqobatdosh kompaniyalar
BIIB (Biogen) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori NBIX (Neurocrine Corp)|Regencell Bioscience - Narxning daromadga nisbati|Axsome Therapeutics - P/S multiplikatori|Bozor kapitallashuvining daromadga nisbati ACAD (ACADIA Pharmaceuticals)|Xenon (XENE) - Narxning daromadga nisbati|Sotuvga nisbatan narx Viking Therapeutics Inc (VKTX)|SUPN (Supernus Pharma) - P/S multiplikatori|CPRX: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori DNLI|Narx/daromad koeffitsiyenti Harmony Biosciences|Biohaven Ltd - Kapitalizatsiyaning daromadga nisbati|P/S multiplikatori Amylyx Pharmaceuticals, Inc. AMLX|TRVI: Kapitalizatsiyaning daromadga nisbati|Narx/daromad koeffitsiyenti Praxis Corp PRAX|AVXL: P/S multiplikatori|CBLL (ceribell.com) - Narxning daromadga nisbati|PRTA (Prothena Corporation) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati alector.com (ALEC)|Narxning daromadga nisbati Annexon, Inc. (ANNX)|OMER - Sotuvga nisbatan narx|P/S multiplikatori NGNE (Neurogene Inc)|AC Immune (ACIU) - Sotuvga nisbatan narx|Voyager Therapeutics Inc - P/S multiplikatori|Neumora (NMRA) - Kapitalizatsiyaning daromadga nisbati|SCLX: P/S multiplikatori|TVGN - Narx/daromad koeffitsiyenti|ACOG (Alpha Cognition Inc) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati cogrx.com (CGTX)|Narxning daromadga nisbati Inhibikase Therapeutics Inc (IKT)|Narx/daromad koeffitsiyenti Cassava Sciences|P/S multiplikatori ASRT (Assertio Holdings)|COYA - Kapitalizatsiyaning daromadga nisbati|vistagen.com - P/S multiplikatori|OVID: Narxning daromadga nisbati|Acumen Pharmaceuticals, Inc (ABOS) - Narxning daromadga nisbati|CervoMed Inc - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Alterity Therapeutics Limited|clene.com (CLNN) - Narx/daromad koeffitsiyenti|Kapitalizatsiyaning daromadga nisbati PEPG (PepGen Inc)|P/S multiplikatori jupiterneurosciences.com (JUNS)|Narxning daromadga nisbati Relmada Therapeutics, Inc. RLMD|ANVS: Kapitalizatsiya va daromad nisbati|Grace Tx - P/S multiplikatori|AIFF (Firefly Neuroscience Inc) - Kapitalizatsiya va daromad nisbati|KLTO: P/S multiplikatori|NeuroSense Therapeutics, Ltd. (NRSN) - P/S multiplikatori|Narxning daromadga nisbati Reviva Pharmaceuticals, Inc.|Kapitalizatsiyaning daromadga nisbati metaviatx.com (MTVA)|P/S multiplikatori NRXS|HSDT - Sotuvga nisbatan narx|Passage Bio, Inc. - Kapitalizatsiyaning daromadga nisbati|bionomics.com.au (NEUP) - Sotuvga nisbatan narx|Minerva - P/S multiplikatori|Bozor kapitallashuvining daromadga nisbati ATHA (Athira Pharma Inc)|ADXN: P/S multiplikatori|Kapitalizatsiya va daromad nisbati ALZN|CYCN (Cyclerion Therapeutics Inc.) - P/S multiplikatori|PTIX (Protagenic Therapeutics) - Kapitalizatsiyaning sotish hajmiga nisbati|P/S multiplikatori KTTA|Narx/daromad koeffitsiyenti Cortigent|P/S multiplikatori ATXI (avenuetx.com)|BrainStorm Cell Therapeutics Inc. - Narxning daromadga nisbati|Cara Therapeutics Inc. - P/S multiplikatori|Chromocell Therapeutics (CHRO) - Kapitalizatsiyaning daromadga nisbati|ELYM: P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati Intra-Cellular Therapies Inc.|LBPH (Longboard Pharmaceuticals Inc) - P/S multiplikatori|Marinus - Narxning sotuvga nisbati|P/S multiplikatori NKGN|SAGE: Narxning sotuvga nisbati|Synaptogenix Inc. - Kapitalizatsiyaning daromadga nisbati|Kapitalizatsiyaning sotish hajmiga nisbati TRVN (Trevena Inc.)|Vigil Neuroscience, Inc. - P/S multiplikatori|Anew Medical (WENA) - Kapitalizatsiyaning daromadga nisbati|CERE (Cerevel Corp) - Kapitalizatsiyaning daromadga nisbati
